Filing Details
- Accession Number:
- 0001140361-22-022671
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-13 06:07:29
- Reporting Period:
- 2022-06-09
- Accepted Time:
- 2022-06-13 06:07:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1350653 | Alphatec Holdings Inc. | ATEC | Surgical & Medical Instruments & Apparatus (3841) | 202463898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427470 | Paul Segal | C/O Ls Power Development, Llc 1700 Broadway, 35Th Floor New York NY 10019 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-09 | 71,129 | $7.18 | 238,625 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-10 | 200 | $7.10 | 238,825 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,410,257 | Indirect | See footnote |
Footnotes
- This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $7.11 to $7.31, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.